Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae

Inflammatory Bowel Diseases

Volumn 5, Issue 4, 1999, Pages 239-245

  Sandborn, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

6 Mercaptopurine; Azathioprine; Combination therapy; Crohn's disease; Perianal fistulae; Tacrolimus FK506

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CROHN DISEASE; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RECTUM FISTULA; RECURRENT DISEASE; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AZATHIOPRINE; CROHN DISEASE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECTAL FISTULA; RECURRENCE; TACROLIMUS; TREATMENT OUTCOME;

EID: 0033228560     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780050402     Document Type: Article

References (7)

1. Flanagan WM, Corthesy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991;352:803-7.
2. The U.S. multicenter FK506 liver study group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-15.
3. Egan LJ, Sandbom WJ, Tremaine WJ. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 1998;93: 442-8.
4. Santos JV, Baudet JA, Casellas FJ, et al. Intravenous cyclosporine for steroid-refractory attacks of Crohn's disease. Short- and longterm results. J Clin Gastroenterol 1995;20:207-10.
5. Abreu-Martin MT, Vasiliauskas EA, Gaiennie J, et al. Continuous infusion cyclosporine in effective for severe acute Crohn's disease...but for how long? Gaslroenterology 1996;110:A851.
6. Keating S, Morrison C, Buckley M, et al. The use of cyclosporin in the management of acute exacerbations of inflammatory bowel disease. Gastroenlerology 1995;108:A846.
7. Bertran X, Fernandez-Banares F, Esteve M, et al. Usefulness of azathioprine to maintain cylosporine induced remission in severe steroid refractory inflammatory bowel disease. Gastroenterology 1995;108:A782.